ALB and cancer: Recently the combination of C-reactive protein and albumin, termed the mGPS, was shown to be associated in a similar manner in patients with lung cancer (Brown et al, 2007) and predict cancer-specific survival in a number of operable (Roxburgh and McMillan, 2010) and inoperable cancers (McMillan, 2009).